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Abstract
Non-steroidal anti inflammatory drugs which were primarily used for the treatment
inflammation and pain have also shown anti-cancer activity in many studies. The
mechanism of action of NSAIDs in cancer may involve cyclooxygenase (COX)
dependent or independent pathways. According to studies, COX-2 is overexpressed in
several cancers such as prostate, breast, nonsmall-cell lung, colon, and pancreas.
Nimesulide is an NSAID with COX-2 inhibitory activity and investigations show that
it could induce apoptosis in cancer. Previously, a library of compounds was synthesized
using Nimesulide as a lead compound. However, they displayed different molecular
targets: tubulin and heat shock protein 27 (HSP27). Since Nimesulide does not interfere
with any of these proteins, the targets of it in cancer remain unclear. Therefore, it is
necessary to identify the original anti-cancer targets of Nimesulide in order to
understand the structure activity relationship that lead to target switching in the
Nimesulide derivatives. For this purpose, a six carbon linker and biotin conjugated
Nimesulide probe was designed and synthesized. A human prostate cancer cell line,
LnCap, was used to perform protein pull-down assay in order to analyze the proteins
that bind to the Nimesulide probe. This study provides insight into the structural
interactions that are important for the anti-cancer activity which can be used to
synthesize more potent analogs with the original target of Nimesulide.
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